Misperceptions of people with disabilities. A bundled payment success story. Do people with COVID-19 tell their employers? The history of vaccine backlash. Oral COVID-19 vaccine? Things are getting better. Vaccines in Gibraltar.
Public health spending lags medical spending. On the importance of pre-analysis protocols. Medicare spends over $10 billion on COVID-19 in 2020. Home health = infrastructure? Will enrollment in cancer clinical trials continue to be difficult post-COVID? Yes vs No.
Health insurance coverage for sexual minorities. PhD = doctor? Ghost rides. Mini-COBRA. Pasaporte corona en Dinamarca.
COVID-19 vaccine monitor. Impact of immunotherapies on Medicare cancer cost. Amazon Care telehealth. What’s wrong with my model? Is Brazil’s health system collapsing?
ISPOR’s new Science Strategy. MedPAC: “CMMI has put 54…[alternative payment] models into practice during the past decade. But only four of them have met the criteria for expansion.” Lifestyle and mental health disruptions since COVID-19. Impact of COVID-19 on small business CDC guidance for the fully vaccinated
Conventional wisdom holds that the U.S. has become more and more partisan and the views of both Democrats and Republicans have become less moderate over time. Is that the case with respect to views on health policy? A paper in JAMA last week by Blendon et al. (2021) conducted probability-based national surveys on four topics…
Food insecurity and health care spending. Access in a new world. Credibility Revolutionistas. Do individuals with limited English proficiency use telehealth? Desk clearing and drug safety. UCI: Re-open California schools
I am very excited to announce that I have joined the FTI Consulting team. An excerpt from the press release is below. WASHINGTON, March 01, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Jason Shafrin, Ph.D. as a Senior Managing Director in the Center for Healthcare Economics and Policy within the firm’s Economic Consulting segment. Dr. Shafrin, who will…
That is a question considered in the latest edition of The Economist. In the article “How British science came to the rescue“, the magazine notes that COVID-19 had highlighted some of the advantages the UK has. Alongside vast clinical trials, the country has been home to most of the world’s genetic sequencing, the development of…
Impact of reducing air pollution on health expenditures. Does psychotherapy work? Does losing health insurance increase claims for SSI? Why governments decide to de-fund medical services. Can nonrandomized RWE replicate RCTs?